Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Consumer & Luxury

Sleep Number Appoints New Finance Chief Amid Strategic Overhaul

Robert Sasse by Robert Sasse
December 5, 2025
in Consumer & Luxury, Earnings, Turnaround
0
Sleep Number Stock
0
SHARES
13
VIEWS
Share on FacebookShare on Twitter

Smart bed manufacturer Sleep Number has named Amy O’Keefe as its new Chief Financial Officer, effective Monday, December 8. The leadership change coincides with a reaffirmation of the company’s full-year 2025 financial outlook, a move interpreted by the market as a sign of stability during an ongoing corporate transformation. Shares in the company responded positively to the dual announcement, climbing nearly 2% in initial trading.

Financial Outlook Maintained

Despite a challenging operating environment, Sleep Number’s management has chosen to stand by its previously stated financial targets for 2025. This confirmation comes just weeks after the company revised its revenue projection downward in November. The reiterated guidance includes the following key metrics:
* Net sales of approximately $1.4 billion
* A gross profit margin near 60%
* Adjusted EBITDA of about $70 million
* Negative free cash flow of roughly $50 million

The decision to uphold these figures suggests the executive team retains confidence in its current stabilization plan, even after the recent sales forecast adjustment from an initial $1.45 billion.

Incoming CFO Brings Deep Transformation Experience

Amy O’Keefe assumes the CFO role with over three decades of experience guiding operational and financial turnarounds, primarily within the consumer goods and technology industries. She joins Sleep Number from Avaya, where she served as Chief Financial and Administrative Officer and played a key role in enhancing the firm’s free cash flow. Her prior executive experience includes holding the top finance position at both Weight Watchers International and Savant Systems.

Should investors sell immediately? Or is it worth buying Sleep Number?

She will succeed interim CFO Bob Ryder, who will support the transition through December 12. O’Keefe’s appointment represents a continuation of the strategic repositioning initiated under CEO Linda Findley. This year alone, Sleep Number has executed extensive restructuring efforts, incurring costs totaling $47.5 million.

Stock Performance and Analyst Sentiment

Sleep Number’s equity has experienced significant volatility following a difficult year, having lost more than 60% of its value over the past twelve months. However, the stock has managed to post modest gains in recent weeks. The current average analyst rating on the shares is “Hold.”

The company’s leadership is scheduled to provide further strategic details at several upcoming investor conferences. The market will be watching closely for insights into how the new financial leadership plans to navigate the company’s path back to sustainable growth and profitability.

Ad

Sleep Number Stock: Buy or Sell?! New Sleep Number Analysis from February 8 delivers the answer:

The latest Sleep Number figures speak for themselves: Urgent action needed for Sleep Number investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 8.

Sleep Number: Buy or sell? Read more here...

Tags: Sleep Number
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Tilray Stock
Analysis

Tilray’s Diversification Strategy Gains Momentum with Key Operational Wins

February 8, 2026
Ammo Stock
Analysis

Outdoor Holding Company’s Pivot Faces Crucial Quarterly Test

February 8, 2026
Oak Valley Stock
Banking & Insurance

Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit

February 8, 2026
Next Post
Bloom Energy Stock

Fueling the AI Revolution: Bloom Energy Shares Surge on Data Center Demand

Apple Stock

Leadership Shifts at Apple Spark Investor Scrutiny Amid Strong Fundamentals

Uranium Energy Stock

A Major Vote of Confidence: Norway's Sovereign Fund Takes a Stake in Uranium Energy

Recommended

Amgen Stock

Amgen’s Market Paradox: Strong Fundamentals Clash With Stock Performance

4 months ago
Adobe Stock

Adobe Shares Plunge to New Depths Amid Institutional Sell-Off

3 months ago
Omv Stock

OMV Shares Stabilize as Romanian Power Plant Resumes Operations

2 months ago
MKL stock news

Lynch Asset Management Inc. Decreases Stake in The Cigna Group, Analysts Offer Mixed Ratings and Price Targets

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Zevra Therapeutics Advances Rare Disease Portfolio with New Data and Strategic Expansion

Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit

SuRo Capital Sharpens Focus on AI Infrastructure Investments

Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic

RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

Trending

Tilray Stock
Analysis

Tilray’s Diversification Strategy Gains Momentum with Key Operational Wins

by Jackson Burston
February 8, 2026
0

Tilray Brands, Inc. continues to build on its strong January performance with two significant strategic developments. The...

Ammo Stock

Outdoor Holding Company’s Pivot Faces Crucial Quarterly Test

February 8, 2026
Berry Petroleum Stock

California Resources Navigates Post-Merger Integration and Regulatory Landscape

February 8, 2026
KemPharm Stock

Zevra Therapeutics Advances Rare Disease Portfolio with New Data and Strategic Expansion

February 8, 2026
Oak Valley Stock

Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tilray’s Diversification Strategy Gains Momentum with Key Operational Wins
  • Outdoor Holding Company’s Pivot Faces Crucial Quarterly Test
  • California Resources Navigates Post-Merger Integration and Regulatory Landscape

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com